Women who have survived breast cancer create a unique patient population in which there is a high occurrence of menopausal symptoms that need to be treated differently. Out of the 240,000 women diagnosed with breast cancer in the United States each year, most have a five-year survival rate of greater than 90%, but are left with some undesirable menopausal symptoms. Due to this, the consequences of menopause have become more significant and challenging to manage in these patients. An estimated half of all women who survive breast cancer develop problems such as vaginal dryness, pain during intercourse, or lower urinary tract infection because of atrophic changes in the vagina and the vulva. Generally, systemic or topical estrogen replacement therapy can be effective in women experiencing these symptoms of menopause. However, this treatment is not suggested for breast cancer survivors since the estrogen or hormones have the potential to contribute to a recurrence of breast cancer.